Xenon Pharmaceuticals (XENE) Debt Ratio (2017 - 2020)

Xenon Pharmaceuticals (XENE) has 4 years of Debt Ratio data on file, last reported at 0.07 in Q1 2020.

• Debt Ratio for Q1 2020 came in at 0.07, down 49.96% year-over-year; the trailing twelve-month figure through Mar 2020 was 0.07 (down 49.96% YoY), and the FY2019 annual result was 0.11, down 14.21% from the prior year.
• Debt Ratio declined to 0.07 in Q1 2020 per XENE's latest filing, from 0.11 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.18 in Q1 2018 and troughed at 0.07 in Q1 2020.
• A 4-year average of 0.13 and a median of 0.14 in 2019 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2019 and 2020: Debt Ratio jumped 36.47% in 2019, then slumped 49.96% in 2020.
• A 4-year view of Debt Ratio shows it stood at 0.15 in 2017, then decreased by 16.87% to 0.12 in 2018, then declined by 14.21% to 0.11 in 2019, then sank by 37.14% to 0.07 in 2020.
• Business Quant data shows XENE's Debt Ratio at 0.07 in Q1 2020, 0.11 in Q4 2019, and 0.16 in Q3 2019.